Healthcare Innovation June 25, 2020
David Raths

Project Patient Voice website seeks to create consistent source of patient-reported symptoms from cancer trials

The U.S. Food and Drug Administration has launched a pilot project to make patient-reported outcome (PRO) data from cancer trials publicly available.

The goal of Project Patient Voice, an initiative of the FDA’s Oncology Center of Excellence (OCE), is to create a consistent source of publicly available information describing patient-reported symptoms from cancer trials for marketed treatments. While this patient-reported data has historically been analyzed by the FDA during the drug approval process, it is rarely included in product labeling and, therefore, is largely inaccessible to the public.

“Project Patient Voice has been initiated by the Oncology Center of Excellence to give patients and healthcare...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Patient / Consumer, Pharma / Biotech
FDA approves Lumicell’s breast cancer imaging tool
Boehringer Ingelheim Strikes Regenerative Med R&D Deal Spanning MASH & More Liver Diseases
Opinion: An FDA pathway can accelerate innovation for Duchenne muscular dystrophy
What principles should guide artificial intelligence innovation in healthcare?
Roche Drug Scores Label Expansion for Earlier Use in Lung Cancer

Share This Article